Altitude Crest Partners Inc.
CIK 1986035
13F portfolio (2024-Q1)
$234M
Positions
30
As reported on this filer's Form 13F for 2024-Q1, filed 2025-02-14. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | LEGN | LEGEND BIOTECH CORP |
| 2 | DHR | DANAHER CORP DEL |
| 3 | BBIO | BRIDGEBIO PHARMA INC |
| 4 | STVN | STEVANATO GROUP S P A |
| 5 | APLS | APELLIS PHARMACEUTICALS INC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →